Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $23.75 and last traded at $24.40, with a volume of 26732 shares. The stock had previously closed at $24.61.
Analyst Ratings Changes
Several equities research analysts recently weighed in on the stock. Bank of America reduced their target price on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. Weiss Ratings lowered shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 4th. Cantor Fitzgerald dropped their price objective on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Stifel Nicolaus decreased their price target on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a research note on Tuesday, March 31st. Finally, Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $42.25.
Read Our Latest Stock Analysis on TRUP
Trupanion Price Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. During the same period last year, the firm earned ($0.03) earnings per share. The business’s revenue for the quarter was up 12.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Trupanion, Inc. will post 0.53 EPS for the current fiscal year.
Insider Buying and Selling at Trupanion
In other Trupanion news, CRO Emily Dreyer sold 7,792 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $28.15, for a total value of $219,344.80. Following the transaction, the executive directly owned 35,627 shares of the company’s stock, valued at approximately $1,002,900.05. This trade represents a 17.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO John R. Gallagher sold 5,283 shares of the firm’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $26.52, for a total transaction of $140,105.16. Following the completion of the transaction, the chief operating officer directly owned 32,387 shares in the company, valued at approximately $858,903.24. The trade was a 14.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 21,503 shares of company stock valued at $578,537. 5.42% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Trupanion
Institutional investors have recently added to or reduced their stakes in the stock. Federated Hermes Inc. bought a new stake in Trupanion in the 3rd quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in Trupanion in the 3rd quarter valued at $39,000. Parallel Advisors LLC lifted its position in Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after acquiring an additional 1,722 shares in the last quarter. Kemnay Advisory Services Inc. bought a new stake in Trupanion in the 4th quarter valued at $64,000. Finally, Kelleher Financial Advisors bought a new stake in Trupanion in the 3rd quarter valued at $74,000.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
- Five stocks we like better than Trupanion
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
